KARBE FRANK - Insider Non-Derivative Transactions at Phathom Pharmaceuticals, Inc. (PHAT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 29, 2024, KARBE FRANK's relationship to Phathom Pharmaceuticals, Inc. (PHAT) is Director, and currently has 44,500 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PHAT insiders.
Data Source: SEC.
KARBE FRANK - Insider Non-Derivative Transactions of PHAT Common Stock
KARBE FRANK - Insider Non-Derivative Transactions at PHAT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 30, 2024 | Acquisition -- (Common Stock) | 25000 | 10.16 | 44500 |
| May 24, 2024 | Acquisition -- (Common Stock) | 10500 | 0 | 19500 |
| May 26, 2023 | Acquisition -- (Common Stock) | 9000 | 0 | 9000 |